(A to E) Experiments were performed using primary kidney perivascular cells isolated from Sphk2PVCWT [wild-type (WT)] and Sphk2PVCKO (Sphk2 KO) mice. (A) MCP-1, IL-6, and CXCL-1 concentrations in supernatants of primary kidney perivascular cells treated with LPS (100 ng/ml) for 24 hours with or without S1P supplementation (100 nM). (B) S1pr1-5 transcript expression at baseline. (C and D) MCP-1, IL-6, and CXCL-1 concentrations in supernatants of WT (C) and Sphk2 KO (D) kidney perivascular cells at 24 hours after treatment with LPS (100 ng/ml). Cells were treated with control, S1pr1, S1pr2, or S1pr3 siRNA before LPS stimulation. (E) MCP-1, IL-6, and CXCL-1 concentrations in supernatants of Sphk2 KO kidney perivascular cells treated with LPS (100 ng/ml) for 24 hours with or without S1P supplementation (100 nM). Cells were treated with control or S1pr1 siRNA before LPS stimulation. n = 6 (A, C, D, and E), n = 5 (B) per group. Data are represented as means ± SEM. *P < 0.05, **P < 0.01, and ***P < 0.001 by two-way (A to D) or one-way (E) ANOVA followed by post hoc multiple comparisons test (Tukey’s).